Lantus competitor Basaglar wins FDA approval December 17, 2015 Lantus competitor Basaglar wins FDA approval The Food and Drug Administration on Dec. 16 approved Lilly’s Basaglar (insulin glargine injection 100 unit/mL), a long-acting human…
